News from the healthcare data industry
DURHAM, N.C., March 29, 2022 /PRNewswire/ — New real-world data evaluating alanine aminotransferase (ALT) in children uncovered disparities in prevalence and severity of non-alcoholic fatty liver disease (NAFLD). The study, Variation in Alanine...
DURHAM, N.C., March 29, 2022 /PRNewswire/ — New real-world data evaluating alanine aminotransferase (ALT) in children uncovered disparities in prevalence and severity of non-alcoholic fatty liver disease (NAFLD). The study, Variation in Alanine...
DURHAM, N.C., March 8, 2022 /PRNewswire/ — A new TARGET-IBD study analysis shows one-third of patients with inflammatory bowel disease (IBD) did not have a record of objective disease activity assessment or therapeutic...
DURHAM, N.C., Nov. 30, 2021 /PRNewswire/ — Target RWE, a leading real-world evidence (RWE) solutions company for the healthcare industry, today announced that Derek Evans, MBA, has joined the company as President. “In...